Delayed bio-stimulant approvals
Approvals for three bio-stimulant products are expected by end of Q4 FY26; any delay could impact Q1 FY27 sales, as peak season starts in July.
Dhanuka Agritech · risk themes across the available quarters.
Bear-case history
Approvals for three bio-stimulant products are expected by end of Q4 FY26; any delay could impact Q1 FY27 sales, as peak season starts in July.
Early El Niño predictions could affect monsoon rains and farmer incomes, potentially reducing demand for agrochemicals in the kharif season.
Transition of Bayer products to Dhanuka's control involves regulatory and supply chain dependencies; any disruption could affect sales.
Inventory of imported molecules increased due to lower-than-expected sales, potentially leading to higher carrying costs or write-downs.